Arterial stiffness is not increased in patients with short duration rheumatoid arthritis and ankylosing spondylitis

被引:13
作者
Dzieza-Grudnik, Anna [1 ]
Sulicka, Joanna [2 ]
Strach, Magdalena [1 ]
Siga, Olga [1 ]
Klimek, Ewa [1 ]
Korkosz, Mariusz [2 ]
Grodzicki, Tomasz [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Internal Med & Gerontol, Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Dept Rheumatol & Balneol, 10 Sniadeckich St, PL-31531 Krakow, Poland
关键词
Arterial stiffness; pulse wave velocity; rheumatoid arthritis; ankylosing spondylitis; cardiovascular risk; endothelial markers; augmentation index; CARDIOVASCULAR-DISEASE RISK; INTIMA-MEDIA THICKNESS; ALL-CAUSE MORTALITY; SUBCLINICAL ATHEROSCLEROSIS; ENDOTHELIAL ACTIVATION; VASCULAR FUNCTION; INFLAMMATION; PREDICTION; ASSOCIATION; PROGRESSION;
D O I
10.1080/08037051.2016.1232586
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) have increased cardiovascular (CV) morbidity and mortality. Arterial stiffness is an independent predictor of CV events. The aim of the study was to assess arterial stiffness and inflammatory markers in patients with short duration chronic arthritis. We assessed carotid-femoral pulse wave velocity (PWV), augmentation index (AIx), traditional CV risk factors and inflammatory and endothelial markers in 71 chronic arthritis patients (RA and AS) and in 29 healthy controls. We did not find differences in PWV (for RA, AS and controls, respectively: 10 [8.8-10.9] versus 10.7 [9.1-11.8] versus 9.2 [8.3-11.4] m/s; p=.14) and AIx (for RA, AS and controls, respectively: 24.3 +/- 11.5 versus 5.7 +/- 12.4 versus 10 +/- 12.8%; p=.22). Both groups of arthritis patients had active disease with significantly elevated inflammatory markers compared to controls. There were no correlations between endothelial and inflammatory markers and parameters of arterial stiffness in arthritis patients. When analyzing arthritis patients according to median of PVW, there were no significant differences in inflammatory and endothelial markers. We found that in patients with short duration active RA and AS arterial stiffness was not increased and furthermore, there was no association between markers of systemic inflammation and arterial stiffness.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 50 条
[41]   Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis [J].
Poddubnyy, Denis ;
Rudwaleit, Martin .
EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) :655-673
[42]   Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis [J].
Han, Chenglong ;
Robinson, Don W. ;
Hackett, Monica V. ;
Paramore, L. Clark ;
Fraeman, Kathy H. ;
Bala, Mohan V. .
JOURNAL OF RHEUMATOLOGY, 2006, 33 (11) :2167-2172
[43]   The relationship between serum YKL-40 levels and arterial stiffness in patients with ankylosing spondylitis [J].
Turkyilmaz, Kucukali A. ;
Devrimsel, G. ;
Beyazal, Serdaroglu M. ;
Kirbas, A. ;
Cicek, Y. ;
Capkin, E. ;
Karkucak, M. ;
Gokmen, F. .
ACTA REUMATOLOGICA PORTUGUESA, 2017, 42 (02) :183-190
[44]   Osteopontin Is Associated with Increased Arterial Stiffness in Rheumatoid Arthritis [J].
Laura Bazzichi ;
Lorenzo Ghiadoni ;
Alessandra Rossi ;
Melania Bernardini ;
Mario Lanza ;
Francesca De Feo ;
Camillo Giacomelli ;
Ilaria Mencaroni ;
Katia Raimo ;
Marco Rossi ;
Anna Maria Mazzone ;
Stefano Taddei ;
Stefano Bombardieri .
Molecular Medicine, 2009, 15 :402-406
[45]   Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease [J].
Mathieu, S. ;
Joly, H. ;
Baron, G. ;
Tournadre, A. ;
Dubost, J. -J. ;
Ristori, J. -M. ;
Lusson, J. -R. ;
Soubrier, M. .
RHEUMATOLOGY, 2008, 47 (08) :1203-1207
[46]   Mortality in rheumatoid arthritis and ankylosing spondylitis [J].
Zochling, J. ;
Braun, J. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) :S127-S130
[47]   Association between arterial stiffness, disease activity and functional impairment in ankylosing spondylitis patients: a cross-sectional study [J].
Avram, Claudiu ;
Dragoi, Razvan Gabriel ;
Popoviciu, Horatiu ;
Dragoi, Mihai ;
Avram, Adina ;
Amaricai, Elena .
CLINICAL RHEUMATOLOGY, 2016, 35 (08) :2017-2022
[48]   Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients [J].
Bonek, Krzysztof ;
Kuca Warnawin, Ewa ;
Kornatka, Anna ;
Plebanczyk, Magdalena ;
Burakowski, Tomasz ;
Maslinski, Wlodzimierz ;
Wislowska, Malgorzata ;
Gluszko, Piotr ;
Ciechomska, Marzena .
BIOMEDICINES, 2022, 10 (04)
[49]   miRNAs as potential biomarkers of treatment outcome in rheumatoid arthritis and ankylosing spondylitis [J].
Wielinska, Joanna ;
Bogunia-Kubik, Katarzyna .
PHARMACOGENOMICS, 2021, 22 (05) :291-302
[50]   Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis [J].
Franke, L. C. ;
Ament, A. J. H. A. ;
van de Laar, M. A. F. J. ;
Boonen, A. ;
Severens, J. L. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) :S118-S123